Hoppenot Herve
- SEC CIK
- 0001596492
In the past year, 1 open-market sale filing worth $19.8M and no purchases.
Current role at each company
- MAZE Maze Therapeutics, Inc.Directoras of Jun 10, 2026
- BCYC Bicycle Therapeutics PLCDirectoras of Jan 6, 2026
- INCY Incyte CorpDirectoras of Dec 10, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $19.8M
- 1 filing
- Net
- −$19.8M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hoppenot Herve as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INCY Incyte Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 (view filing) | Nov 10 | 2 days | Hoppenot HerveDirector | SSale | −187.5K | $105.46 | −$19.8M | −36.3%329.6K after | 10b5-1 |